Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study

Xiaolong Qi, Yanna Liu, Jitao Wang, Jonathan A Fallowfield, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C Rockey, COVID-Cirrhosis-CHESS Group, Xiaolong Qi, Yanna Liu, Jitao Wang, Jonathan A Fallowfield, Jianwen Wang, Xinyu Li, Jindong Shi, Hongqiu Pan, Shengqiang Zou, Hongguang Zhang, Zhenhuai Chen, Fujian Li, Yan Luo, Mei Mei, Huiling Liu, Zhengyan Wang, Jinlin Li, Hua Yang, Huihua Xiang, Xiaodan Li, Tao Liu, Ming-Hua Zheng, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Ning Kang, Qing He, Ye Gu, Guo Zhang, Chuxiao Shao, Dengxiang Liu, Lin Zhang, Xun Li, Norifumi Kawada, Zicheng Jiang, Fengmei Wang, Bin Xiong, Tetsuo Takehara, Don C Rockey, COVID-Cirrhosis-CHESS Group

No abstract available

Keywords: infectious disease; liver cirrhosis.

Conflict of interest statement

Competing interests: None declared.

References

    1. Bezzio C, Saibeni S, Variola A, et al. . Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut 2020;69:1213–7. 10.1136/gutjnl-2020-321411
    1. Zhang C, Shi L, Wang F-S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020;5:428–30. 10.1016/S2468-1253(20)30057-1
    1. Gacouin A, Locufier M, Uhel F, et al. . Liver cirrhosis is independently associated with 90-day mortality in ARDS patients. Shock 2016;45:16–21. 10.1097/SHK.0000000000000487
    1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020. 10.1001/jama.2020.2648. [Epub ahead of print: 24 Feb 2020] (Epub ahead of print: 24 Feb 2020).
    1. Onder G, Rezza G, Brusaferro S. Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020. 10.1001/jama.2020.4683. [Epub ahead of print: 23 Mar 2020].
    1. Jepsen P, Vilstrup H, Andersen PK, et al. . Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 2008;48:214–20. 10.1002/hep.22341
    1. Guan WJ, ZY N, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020.
    1. Wang D, Hu B, Hu C, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. 10.1001/jama.2020.1585. [Epub ahead of print: 07 Feb 2020].
    1. Li L-Q, Huang T, Wang YQ, et al. . COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020.
    1. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020;506:145–8. 10.1016/j.cca.2020.03.022

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj